Tryg A/S – Interim report Q2 and H1 2014 Tryg’s

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Tryg A/S – Interim report Q2 and H1 2014

Tryg’s Supervisory Board has today approved the interim report for Q2 and H1 2014.

Improvement in Tryg’s performance
Substantial improvement in performance and enhanced development trend in premium income. Results are positively impacted by one-off effects, reflected in a low expense ratio. The efficiency programme also shows consistent progress.

Financial highlights for Q2 2014 

  • Profit before tax of DKK 1,150m (DKK 688m).
  • Technical result of DKK 941m (DKK 684m).
  • Combined ratio improved by 6.0 percentage points to 80.7 (86.7).
  • 1.2% (-2.6%) decline in premium income – but enhanced development trend.
  • Expense ratio of 12.6 (15.6) positively impacted by one-off effects of DKK 135m.
  • Investment return of DKK 259m (DKK 13m) boosted by positive financial markets.
  • Return on equity of 32.1% (18.7%) p.a. after tax.

 
Financial highlights for H1 2014

  • Profit before tax of DKK 1,752m (DKK 1,447m).
  • Technical result of DKK 1,464m (DKK 1,184m).
  • Combined ratio improved by 3.7 percentage points to 84.9 (88.6).
  • 1.6% (-2.5%) decline in premium income – but enhanced development trend.
  • Expense ratio of 14.2 (15.8) positively impacted by one-off effects of DKK 135m.
  • Investment return of DKK 348m (DKK 282m) boosted by positive financial markets.
  • Return on equity of 24.5% (20.4%) p.a. after tax.

 
Statement by Group CEO Morten Hübbe:
The improved results for Q2 show that our efficiency measures are working. We improved the combined ratio and, even when disregarding the extraordinary one-off effects, achieved a lower expense ratio. This is strengthening our competitiveness and creating a sound basis for our continued efforts to provide peace of mind and value for our customers, employees and shareholders. At the same time, we see an improvement in premium development, however, there is still some way to go before this will translate into top-line growth.

We are very pleased with the positive developments and trends seen in several areas. After a period of decline, Private Norway is attracting increasing customer numbers, while the trend is also improving in Private Denmark. At the same time, both Denmark and Norway are realising improved customer renewal figures in the Commercial segment.

Our customers must feel confident about their choice of Tryg every time they are in contact with us. We have therefore launched a number of initiatives under the heading ‘Customer journey & success culture’, including, for example, extended opening hours, sms-based customer surveys and training programmes for both managers and employees designed to ensure a strong customer focus in everything we do.

Results for Q2 were negatively impacted by one-off expenses in connection with the current change of IT provider based on a need to ensure increased operational stability during the transitional phase for the benefit of both customers and employees. In addition, cost levels were positively affected by a new pension agreement for Tryg’s employees in Norway. Under the new agreement, several years of inappropriately high levels of tied-up capital have been replaced by a far more stable scheme.

Conference call
Tryg hosts a conference call on the day of the release at 9:30 CET. CEO Morten Hübbe and CFO Tor Magne Lønnum will present the results in brief followed by a Q&A session. The conference call will be held in English.

Conference call details:

Danish participants: +45 35 44 55 83
UK participants:       +44 (0) 203 194 0544
US participants:       +1 855 269 2604


Additional information:
 For further information, please contact:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading